Oncology
Matthew Pianko, M.D.
Clinical Associate Professor of Internal Medicine, Division of Hematology/Oncology, University of Michigan Medical School
Dr. Matthew Pianko is a hematologist and clinical investigator specializing in plasma cell disorders and hematologic malignancies, with particular expertise in multiple myeloma and related conditions. His clinical focus includes multiple myeloma, smoldering multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), light chain (AL) amyloidosis, plasmacytoma, POEMS syndrome, and monoclonal immunoglobulin/light chain deposition disease. Dr. Pianko is committed to clinical researc
15+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine)
- Hematology (American Board of Internal Medicine)
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- Stanford University School of Medicine — M.D., 2011
- NewYork-Presbyterian Hospital/Columbia University Irving Medical Center — Internal Medicine Residency, 2011-2014
- Memorial Sloan Kettering Cancer Center — Fellowship in Hematology and Medical Oncology, 2015-2018
Peer Recognition
- Arnold P. Gold Foundation — Humanism and Excellence in Teaching Award
2013
- Castle Connolly — Top Doctor
2023-2026 (4 years)
- The Lymphoma Foundation of MSKCC — Mortimer P. Lacher Fellowship
2017-2018 (2 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- University of Michigan Medical Center
- University of Michigan Rogel Cancer Center
- Michigan Medicine Pulmonary Clinic, Taubman Center
Languages
English, Spanish
Experience
15+ years in practice